title: [Hepatorenal syndrome in decompensated cirrhosis : A special form of acute renal failure].
abstract: Renal failure is a serious complication in patients with advanced cirrhosis. It occurs in about 20 % of patients hospitalized with cirrhosis. In about 70 % it is caused by prerenal failure, and in 30 % it is due to intrarenal causes. In about 70 % of patients with rperenal failure, renal function can be restored with fluid replacement, but the remaining 30 % are unresponsive to volume expansion. Minor increase in serum creatinine have been shown to be clinically relevant and can adversely affect survival. Therefore early efforts should be made to avoid precipitation of renal failure.Hepatorenal syndrome (HRS) is a  fully reversible impairment of renal function in patients with cirrhosis unresponsive to volume expansion characterized by an acute progressive decrease in kidney function (serumcreatinin > 1,5 mg/dl) - type 1 HRS, whereas type 2 HRS features a decrease in kidney function over a long time, mostly in patients with refractory ascites. Therapy with vasoconstrictors like terlipressin to reverse splanchnic vasodilation, together with albumin is effective in 30-50 % of patients with HRS 1 and improves survival. The only effective longterm therapy is livertransplantation. An improvement of kidney fuction before transplantation is associated with a better outcome and posttransplant kidney function.
authors.affiliation: Abteilung für Innere Medizin und Intensivmedizin, Konventhospital der Barmherzigen Brüder Linz, Seilerstätte 2, 4020, Linz, Österreich. kurt.lenz@meduniwien.ac.at.
authors.forename: K
authors.initials: K
authors.lastname: Lenz
authors.affiliation: Abteilung für Innere Medizin und Intensivmedizin, Konventhospital der Barmherzigen Brüder Linz, Seilerstätte 2, 4020, Linz, Österreich.
authors.forename: R
authors.initials: R
authors.lastname: Buder
authors.affiliation: Abteilung für Innere Medizin und Intensivmedizin, Konventhospital der Barmherzigen Brüder Linz, Seilerstätte 2, 4020, Linz, Österreich.
authors.forename: G
authors.initials: G
authors.lastname: Lohr
authors.affiliation: Abteilung für Innere Medizin und Intensivmedizin, Konventhospital der Barmherzigen Brüder Linz, Seilerstätte 2, 4020, Linz, Österreich.
authors.forename: P
authors.initials: P
authors.lastname: Piringer
authors.affiliation: Abteilung für Innere Medizin und Intensivmedizin, Konventhospital der Barmherzigen Brüder Linz, Seilerstätte 2, 4020, Linz, Österreich.
authors.forename: M
authors.initials: M
authors.lastname: Voglmayr
mesh_terms: D003422:Critical Care; D005440:Fluid Therapy; D006530:Hepatorenal Syndrome / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy; D006801:Humans; D007677:Kidney Function Tests; D008103:Liver Cirrhosis / Q000150:complications* / Q000175:diagnosis* / Q000628:therapy; D017093:Liver Failure / Q000175:diagnosis* / Q000628:therapy*; D016031:Liver Transplantation; D008236:Lypressin / Q000031:analogs & derivatives / Q000627:therapeutic use; D011379:Prognosis; D012709:Serum Albumin / Q000008:administration & dosage; D000077585:Terlipressin; D014662:Vasoconstrictor Agents / Q000627:therapeutic use
chemical_list: D012709:Serum Albumin; D014662:Vasoconstrictor Agents; D008236:Lypressin; D000077585:Terlipressin
keywords: Ascites; Hepatitis; Kidney diseases; Liver diseases; Peritonitis